Pharmaceuticals (11)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Completion of Recovery Certificate No. 4355 of 2021 Against Venmax Drugs and Pharmaceuticals Limited SEBI has completed Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C), … | |||||||||||||||
SEBI has completed Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C), signifying successful conclusion of the recovery proceedings.
| |||||||||||||||
SEBI issues a release order for Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: … | |||||||||||||||
SEBI issues a release order for Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C), indicating the recovery proceedings have been concluded.
| |||||||||||||||
BSE lists 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on a preferential basis at Rs. 1250/- per share, effective … | |||||||||||||||
BSE lists 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on a preferential basis at Rs. 1250/- per share, effective March 4, 2026, with a lock-in period until September 15, 2026.
| |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, adjusting recovery enforcement terms.
| |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, amending previously attached assets or attachment details in ongoing recovery proceedings.
| |||||||||||||||
BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code 524314) issued to promoters on a preferential basis, … | |||||||||||||||
BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code 524314) issued to promoters on a preferential basis, effective February 25, 2026. Shares are locked in until June 16, 2027.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per equity share under SEBI (SAST) Regulations.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited's expanded share … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited's expanded share capital at INR 1,639.18 per equity share under SEBI (SAST) Regulations.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of expanded share capital of J.B. Chemicals & Pharmaceuticals … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of expanded share capital of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per equity share.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 4.17 crore equity shares (26% of expanded share capital) of J.B. … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 4.17 crore equity shares (26% of expanded share capital) of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per share.
| |||||||||||||||